Evidence map›Paper›PMID 37013538›Full record

Observational studyBMC pediatrics2023

Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.

Anuradha Rajamanickam, Aishwarya Venkataraman, Nathella Pavan Kumar, R Sasidaran, Arul Nancy Pandiarajan, Nandhini Selvaraj, Ruchi Mittal, K Gowshika, Sulochana Putlibai, S Lakshan Raj and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Anuradha Rajamanickam *National Institutes of Health-National Institute for Research in Tuberculosis - International Center for Excellence in Research, Chennai, India. anuradha@icerindia.org.
Aishwarya Venkataraman *ICMR-National Institute for Research in Tuberculosis, Chennai, India.
Nathella Pavan KumarICMR-National Institute for Research in Tuberculosis, Chennai, India.
R SasidaranKanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
Arul Nancy PandiarajanNational Institutes of Health-National Institute for Research in Tuberculosis - International Center for Excellence in Research, Chennai, India.
Nandhini SelvarajNational Institutes of Health-National Institute for Research in Tuberculosis - International Center for Excellence in Research, Chennai, India.
Ruchi MittalSri Ramachandra Institute of Higher Education & Research, Chennai, India.
K GowshikaSri Ramachandra Institute of Higher Education & Research, Chennai, India.
Sulochana PutlibaiKanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
S Lakshan RajKanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
Padmasani Venkat Ramanan *Sri Ramachandra Institute of Higher Education & Research, Chennai, India.
Subash Babu *National Institutes of Health-National Institute for Research in Tuberculosis - International Center for Excellence in Research, Chennai, India.
Kanchi Kamakoti CHILDS Trust Hospital · INSri Ramachandra Institute of Higher Education and Research · INNational Institute of Research in Tuberculosis · INInternational Centers for Excellence in Research · INNational Institutes of Health · US

Funding

India International Center for Excellence in ResearchZIAAI001065 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$19.0M
6 · The paper itself

Abstract

backgroundThe Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), accountable for Coronavirus disease 2019 (COVID-19), may cause hyperglycemia and additional systemic complexity in metabolic parameters. It is unsure even if the virus itself causes type 1 or type 2 diabetes mellitus (T1DM or T2DM). Furthermore, it is still unclear whether even recuperating COVID-19 individuals have an increased chance to develop new-onset diabetes.

methodsWe wanted to determine the impact of COVID-19 on the levels of adipokines, pancreatic hormones, incretins and cytokines in acute COVID-19, convalescent COVID-19 and control children through an observational study. We performed a multiplex immune assay analysis and compared the plasma levels of adipocytokines, pancreatic hormones, incretins and cytokines of children presenting with acute COVID-19 infection and convalescent COVID-19.

resultsAcute COVID-19 children had significantly elevated levels of adipsin, leptin, insulin, C-peptide, glucagon and ghrelin in comparison to convalescent COVID-19 and controls. Similarly, convalescent COVID-19 children had elevated levels of adipsin, leptin, insulin, C-peptide, glucagon, ghrelin and Glucagon-like peptide-1 (GLP-1) in comparison to control children. On the other hand, acute COVID-19 children had significantly decreased levels of adiponectin and Gastric Inhibitory Peptide (GIP) in comparison to convalescent COVID-19 and controls. Similarly, convalescent COVID-19 children had decreased levels of adiponectin and GIP in comparison to control children. Acute COVID-19 children had significantly elevated levels of cytokines, (Interferon (IFN)) IFNγ, Interleukins (IL)-2, TNFα, IL-1α, IL-1β, IFNα, IFNβ, IL-6, IL-12, IL-17A and Granulocyte-Colony Stimulating Factors (G-CSF) in comparison to convalescent COVID-19 and controls. Convalescent COVID-19 children had elevated levels of IFNγ, IL-2, TNFα, IL-1α, IL-1β, IFNα, IFNβ, IL-6, IL-12, IL-17A and G-CSF in comparison to control children. Additionally, Principal component Analysis (PCA) analysis distinguishes acute COVID-19 from convalescent COVID-19 and controls. The adipokines exhibited a significant correlation with the levels of pro-inflammatory cytokines.

conclusionChildren with acute COVID-19 show significant glycometabolic impairment and exaggerated cytokine responses, which is different from convalescent COVID-19 infection and controls.

Indexed as

COVID-19Diabetes Mellitus, Type 2AdipokinesAdiponectinChildComplement Factor DC-PeptideCytokinesGhrelinGlucagonGranulocyte Colony-Stimulating FactorHumansIncretinsInterleukin-12Interleukin-17Interleukin-6AdipokinesAdiponectinComplement Factor DC-PeptideCytokinesGhrelinGlucagonGranulocyte Colony-Stimulating FactorIncretinsInterleukin-12Interleukin-17Interleukin-6LeptinPancreatic HormonesTumor Necrosis Factor-alphaAcute COVID-19 childrenAdipokinesConvalescent COVID-19 childrenPancreatic hormones and Incretins

Identifiers

PMID37013538
PMCPMC10068212
OpenAlexW4362522939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.